Kerry Holford

Item: Kerry Holford
Rating: 2.15
Author: StockAnalysis.com

Stock Analyst at Berenberg

(2.15)

# 2,926

Out of 5,044 analysts

Total ratings

42.86%

Success rate

11.56%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Kerry Holford

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NVO Novo Nordisk	Upgrades: Buy	n/a	$52.14	-	1	Sep 17, 2025
	LLY Eli Lilly and Company	Downgrades: Hold	$970 → $830	$827.67	+0.28%	9	Sep 17, 2025

Novo Nordisk

Sep 17, 2025

Upgrades: Buy

Price Target: n/a

Current: $52.14

Upside: -

Eli Lilly and Company

Sep 17, 2025

Downgrades: Hold

Price Target: $970 → $830

Current: $827.67

Upside: +0.28%